Ewa Lech-Maranda

Ewa Lech-Maranda

UNVERIFIED PROFILE

Are you Ewa Lech-Maranda?   Register this Author

Register author
Ewa Lech-Maranda

Ewa Lech-Maranda

Publications by authors named "Ewa Lech-Maranda"

Are you Ewa Lech-Maranda?   Register this Author

71Publications

1891Reads

46Profile Views

Outcomes of treatment with dose-adjusted EPOCH-R or R-CHOP in primary mediastinal large B-cell lymphoma.

Eur J Haematol 2020 Jan 27;104(1):59-66. Epub 2019 Oct 27.

Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13337DOI Listing
January 2020

Prophylaxis of hepatitis B virus (HBV) infection reactivation - recommendations of the Working Group for prevention of HBV reactivation.

Clin Exp Hepatol 2019 Sep 5;5(3):195-202. Epub 2019 Sep 5.

Department of Paediatrics, Haematology and Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/ceh.2019.87631DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781818PMC
September 2019

Defective Sphingolipids Metabolism and Tumor Associated Macrophages as the Possible Links Between Gaucher Disease and Blood Cancer Development.

Int J Mol Sci 2019 Feb 15;20(4). Epub 2019 Feb 15.

Department of Microbiological and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2C, 15-222 Bialystok, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20040843DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412850PMC
February 2019

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.

N Engl J Med 2018 01 10;378(4):331-344. Epub 2017 Dec 10.

From the University of British Columbia and the Department of Medical Oncology, British Columbia Cancer Agency Centre for Lymphoid Cancer, Vancouver, Canada (J.M.C., K.J.S.); the Department of Hematology, Jagiellonian University, Krakow (W.J.), the Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw (E.L.-M.), the Department of Hematology and Transfusion Medicine, Center of Postgraduate Medical Education, Warsaw (E.L.-M.), the Department of Experimental Hematology, Medical University of Lodz, Lodz (P.S.), and the Department of Lymphoid Malignancy, the Maria Sklodowska-Curie Memorial Institute and Oncology Center, Warsaw (J.W.) - all in Poland; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (D.J.S., A.Y.); the Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN (S.M.A.); the Division of Hematology and Oncology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea (W.S.K.); Research Innovation and Statistics, Antoine-Lacassagne Cancer Center, Nice, France (A.G.); Petrov Research Institute of Oncology, St. Petersburg, Russia (S.A.); the Department of Hematology, Faculty of Medicine, University of Debrecen, Debrecen (Á.I.), and the Department of Hematology, National Institute of Oncology, Budapest (A.R.) - both in Hungary; the Department of Advanced Biomedical Science, Federico II University Hospital, Naples (M.P.), and the Institute of Hematology Seràgnoli, University of Bologna, Bologna (P.L.Z.) - both in Italy; the Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston (Y.O.); John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ (T.F.); the Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis (N.L.B.); the Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA (R.C.); the Department of Hematology-Oncology, Barbara Ann Karmanos Cancer Center, Detroit (R.R.); Gastrointestinal and Lymphoma Unit, The Royal Marsden NHS Foundation Trust, Sutton (D.C.), and the Department of Medical Oncology, University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester (J.R.) - both in the United Kingdom; the Department of Clinical Development, Seattle Genetics, Bothell, WA (N.C.J., E.S.); and Oncology Clinical Research (J.S., H.A.J., D.H.) and Global Biostatistics (R.L.), Millennium Pharmaceuticals, Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1708984DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819601PMC
January 2018

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.

N Engl J Med 2017 03;376(9):836-847

From the Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston (H.K.); City of Hope National Medical Center, Duarte (A.S.), and Amgen, Thousand Oaks (A.F., D.N., Z.Z.) - both in California; Goethe University, University Hospital, Department of Medicine II, Frankfurt am Main (N.G.), Medical Department II (H.-A.H., M.B.) and Hematopathology Section and Lymph Node Registry (W.K.), University Hospital Schleswig Holstein, Campus Kiel, Kiel, and Medizinische Klinik und Poliklinik II, Universitätsklinikums Würzburg, Würzburg (M.S.T.) - all in Germany; Royal Free Hospital and University College London Cancer Institute, London (A.K.F.); Princess Margaret Cancer Centre, Toronto (A.C.S.), and Centre Intégré Universitaire de Santé et de Services Sociaux de l'est de l'île de Montréal, Hôpital Maisonneuve-Rosemont, Montreal (J.B.) - all in Canada; ICO-Hospital Universitari Germans Trias i Pujol, Jose Carreras Research Institute, Universitat Autonoma de Barcelona, Barcelona (J.-M.R.), the Department of Medicine, Hospital Universitari i Politecnic La Fe, University of Valencia, Valencia, and Centro de Investigación Biomédica en Red de Cáncer, Instituto Carlos III, Madrid (M.A.S.) - all in Spain; Alfred Hospital and Monash University, Melbourne, VIC, Australia (A.W.); Institut Universitaire d'Hématologie, Hôpital Saint-Louis (Assistance Publique - Hôpitaux de Paris), Paris (H.D.), and Centre Hospitalier Lyon Sud, Pierre-Benite (X.T.) - both in France; Ematologia, Dipartimento di Biotecnologie Cellulari ed Ematologia, Azienda Ospedaliera Policlinico Umberto I, Università Sapienza di Roma, Rome (R.F.), Azienda Unità Locale Socio Sanitaria 12 Veneziana Ospedale Dell Angelo, Venice (R.B.), and Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Università Statale di Milano, Milan (A.R.) - all in Italy; Ankara Universitesi, Tip Fakültesi, Cebeci Arastirma ve Uygulama Hastanesi, Ankara (Ö.A.), and Dokuz Eylül Üniversitesi Tıp Fakültesi, İzmir (F.D.) - both in Turkey; Instytut Hematologii i Transfuzjologii and Centrum Medyczne Kształcenia Podyplomowego, Warsaw, Poland (E.L.-M.); University of Washington Medical Center, Seattle (B.L.W.); and Amgen, Washington, DC (C.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1609783DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881572PMC
March 2017

High incidence of intact or fragmented immunoglobulin in urine of patients with multiple myeloma.

Leuk Lymphoma 2015 13;56(12):3348-56. Epub 2015 May 13.

a Department of Diagnostics for Hematology , Institute of Hematology and Transfusion Medicine , Warsaw , Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1037753DOI Listing
September 2016

HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma.

Arch Immunol Ther Exp (Warsz) 2016 Jun 14;64(3):225-40. Epub 2015 Dec 14.

Department of Hematology, Institute of Hematology and Transfusion Medicine, Indiry Gandhi 14, 02-776, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00005-015-0372-8DOI Listing
June 2016

Hodgkin's lymphoma mimicking tuberculosis in cervical lymph nodes.

Pol J Pathol 2014 Mar;65(1):83-8

Anna Szumera-Ciećkiewicz Department of Diagnostic Hematology Institute of Hematology and Transfusion Medicine I. Gandhi 14 02-776 Warsaw, Poland tel. +48 22 349 62 96 fax +48 22 349 64 94 e-mail:

View Article

Download full-text PDF

Source
March 2014

Novel systemic drugs for cutaneous T-cell lymphoma.

Recent Pat Anticancer Drug Discov 2011 Jan;6(1):70-93

Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, 93-513 Lodz, Ciolkowskiego 2, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/157489211793980051DOI Listing
January 2011

Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.

Expert Rev Anticancer Ther 2010 Oct;10(10):1529-43

Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, 93-510 Lodz, ul. Ciołkowskiego 2, Poland.

View Article

Download full-text PDF

Source
http://www.hematologylibrary.org/site/webfocus/content/8-jco
Web Search
http://www.tandfonline.com/doi/full/10.1586/era.10.132
Publisher Site
http://dx.doi.org/10.1586/era.10.132DOI Listing
October 2010

Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity.

Mini Rev Med Chem 2009 Jun;9(7):805-12

Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Pabianicka 62 str, 93-513 Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138955709788452586DOI Listing
June 2009

Toll-like receptors and their role in carcinogenesis and anti-tumor treatment.

Cell Mol Biol Lett 2009 18;14(2):248-72. Epub 2008 Dec 18.

Department of Hematology, Medical University of Łódź, Ciołkowskiego 2, 93-513 Łódź, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2478/s11658-008-0048-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275910PMC
April 2009

Toll-like receptors and their role in hematologic malignancies.

Curr Mol Med 2009 Apr;9(3):324-35

Department of Hematology, Medical University of Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/156652409787847182DOI Listing
April 2009

Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.

Molecules 2009 Mar 23;14(3):1183-226. Epub 2009 Mar 23.

Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, 93-510 Lodz, Ciolkowskiego 2 Str., Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/molecules14031183DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253893PMC
March 2009

Novel purine nucleoside analogues for hematological malignancies.

Recent Pat Anticancer Drug Discov 2008 Jun;3(2):123-36

Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Pabianicka 62, 93-513 Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/157489208784638811DOI Listing
June 2008

Cytotoxic activity of the selected pyridinium salts against murine leukemia L1210.

Pharmacol Rep 2007 Mar-Apr;59(2):216-23

Institute of Applied Radiation Chemistry, Technical University of Łódź, Zeromskiego 116, PL 90-924 Łódź, Poland.

View Article

Download full-text PDF

Source
January 2008

Depsipeptide (FK228) as a novel histone deacetylase inhibitor: mechanism of action and anticancer activity.

Mini Rev Med Chem 2007 Oct;7(10):1062-9

Department of Hematology, Medical University of Lodz, Copernicus Hospital, Ciolkowskiego 2 st, 93-510 Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138955707782110178DOI Listing
October 2007

Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity.

Curr Med Chem 2006 ;13(26):3165-89

Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Pabianicka 62, Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/092986706778742918DOI Listing
February 2007

Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma.

Eur Cytokine Netw 2006 Mar;17(1):60-6

Equipe d'Accueil Pathologie des Cellules Lymphoïdes, Université Claude Bernard, Lyon, France.

View Article

Download full-text PDF

Source
March 2006

Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.

Eur Cytokine Netw 2003 Jul-Sep;14(3):149-53

Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Pabianicka 62, 93-513 Lodz, Poland.

View Article

Download full-text PDF

Source
June 2004

Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma.

Blood 2004 May 30;103(9):3529-34. Epub 2003 Dec 30.

Equipe d'Accueil 3737 Pathologie des Cellules Lymphoïdes, Université Claude Bernard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2003-06-1850DOI Listing
May 2004